Insider trade

Insulet Corporation (PODD): Officer sold ~$390K

Dan Manea, Officer at Insulet Corporation, sold ~$390K of Insulet Corporation shares.

~$390K
Approx. value · 1,300 sh @ $300.05
9,090
Holds after · shares reported
Traded
Jun 13, 2025
Filed
Jun 16, 2025

What stands out in this filing

  • The sale was 12.5% of the shares this insider held before it; the filing reports 9,090 shares afterwards.
  • 1,300 shares at an average of $300.05 each, as reported on the form.
  • Footnote references a pre-arranged trading plan (Rule 10b5-1).

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jan 3, 2023CongressDisclosed purchase of PODD — reported range $1,001 - $15,000
  2. Jan 4, 2024CongressDisclosed sale of PODD — reported range $1,001 - $15,000
  3. May 13, 2025Insider · 2 peopleInsiders: 2 sales (~$2.6M)
  4. May 14, 2025InsiderOfficer sold ~$1.68M of PODD shares in the open market
  5. May 23, 2025FDARecall: Omnipod 5 Automated Insulin Delivery System, iOS Application. Model Number: PT-000664/M009-S-AP. Software Version: all Product Description: The Omnipod 5 iOS A…
  6. Jun 9, 2025InsiderDirector sold ~$147K of PODD shares in the open market
  7. Jun 13, 2025 · this disclosureInsiderOfficer sold ~$390K of PODD shares in the open market

What came next

  1. Jun 13, 2025InsiderOfficer sold ~$698K of PODD shares in the open market
  2. Aug 7, 2025InsiderOfficer sold ~$430K of PODD shares in the open market
  3. Aug 21, 2025InsiderOfficer sold ~$1.42M of PODD shares in the open market
  4. Sep 8, 2025Insider · 2 peopleInsiders: 2 sales (~$517K)
  5. Sep 11, 2025Company filing · Form 8-K · Executive change, Other newsChanged a top executive or board member, and reported other company news“On September 16, 2025, Insulet Corporation (the “Company”) announced that Flavia H. Pease has been appointed to succeed Ana M. Chadwick as Executive Vice President and Chief Financial Officer of the Company.”
  6. Sep 11, 2025FDARecall: The failure occurs if a user on the Omnipod 5 iOS application selects and holds down on a manual entry field, to magnify the visual field using the magnifying…
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Insulet Corporation

For Insulet Corporation, OQRO holds 3 Congress trade reports and 3 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PODD page.

How this filing works

Explore the data

Common questions

Which Insulet Corporation (PODD) insider traded, and how much?

Dan Manea, Officer at Insulet Corporation, sold ~$390K of Insulet Corporation shares. 1,300 shares at $300.05.

When did it happen, and when was it made public?

Traded: Jun 13, 2025. Filed: Jun 16, 2025. That is 3 days between the two dates.

What stands out in this filing?

The sale was 12.5% of the shares this insider held before it; the filing reports 9,090 shares afterwards. 1,300 shares at an average of $300.05 each, as reported on the form. Footnote references a pre-arranged trading plan (Rule 10b5-1).

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Insulet Corporation recently?

For Insulet Corporation, OQRO holds 3 Congress trade reports and 3 fund holdings reports (13F) dated in the last 90 days. They are listed on the PODD page.

Does this mean PODD stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Insulet Corporation

Everything OQRO holds on this company is on its PODD page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data